Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Neoplasm
88%
Recombinant Bone Morphogenetic Protein 4
80%
Clinical Trial
80%
Oncolytic Adenovirus
80%
Adverse Event
48%
Inflammation
40%
Steroid Treatment
20%
Intracranial Hypertension
20%
Cytokine
20%
CD8 Antigen
20%
Virus DNA
20%
Virus Meningitis
20%
CD3 Antigen
20%
Malignant Neoplasm
16%
Maximum Tolerated Dose
16%
Long Term Survival
8%
Human Study
8%
Tumor Growth
8%
Clinical Study
8%
Medicine and Dentistry
Oncolytic Adenovirus
80%
Clinical Trial
80%
Neoplasm
80%
Cerebrospinal Fluid
40%
Serositis
40%
Virus Shedding
40%
Adverse Event
40%
Immune Response
20%
Virus Replication
20%
Magnetic Resonance Imaging
20%
Cytotoxic T-Cell
20%
Macrophage
20%
T-Helper Cell
20%
Cytokine
20%
Virus DNA
20%
Virus Meningitis
20%
Intracranial Hypertension
20%
Natural Killer Cell
20%
Steroid Treatment
20%
Glioblastoma
20%
CD3 Antigen
20%